• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • ResearchMatch (RM)
    • Biomarkers
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
How New Therapies Are Revolutionizing the Treatment of Juvenile Idiopathic Arthritis.

How New Therapies Are Revolutionizing the Treatment of Juvenile Idiopathic Arthritis.

by William Jester | Mar 12, 2025 | Community, News

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to Rutgers Health researchers. Their study, published in Arthritis & Rheumatology, examined more than 20...
NJIT’s Grace Hopper AI Research Institute Launches with $1 Million in Research Proposals.

NJIT’s Grace Hopper AI Research Institute Launches with $1 Million in Research Proposals.

by William Jester | Mar 11, 2025 | Community, News

New Jersey Institute of Technology (NJIT) has taken a significant step in its commitment to advancing artificial intelligence by establishing the Grace Hopper AI Research Institute (GHRI). The institute is a key component of NJIT’s $10 million AI Initiative...

Opioid addiction recovery gets boost in NJ as Rutgers opens treatment center, jobs website.

by William Jester | Mar 9, 2025 | Community, News

New Jersey is expanding its support for residents affected by the opioid epidemic and other substance use disorders, through two new initiatives announced by Rutgers University. In partnership with the state Labor Department, Rutgers launched a Pathways to...
NJII Launches AI Division to Help Businesses Harness Artificial Intelligence.

NJII Launches AI Division to Help Businesses Harness Artificial Intelligence.

by William Jester | Mar 8, 2025 | Community, News

New Jersey Innovation Institute (NJII), an NJIT corporation, announced the launch of its fifth division, Artificial Intelligence and Machine Learning, featuring New Jersey’s first and only AI Job Shop. This innovative division bridges the growing gap between...
Princeton geoscientists propose an unexpected new screening tool for cancer.

Princeton geoscientists propose an unexpected new screening tool for cancer.

by William Jester | Mar 7, 2025 | Community, News

Princeton geoscientists Xinning Zhang and Ashley Maloney have discovered that a geology technique shows promise in detecting cancer-like cells. If their preliminary results bear out, they may have identified a new signature for cancer, which could mean earlier...
« Older Entries
Next Entries »

Recent Posts

  • Researchers Investigate How to Integrate Behavioral Health into Primary Care.
  • Scientists map the half-billion connections that allow mice to see.
  • New COVID-19 Drug Shows Greater Promise Against Resistant Viral Strains.
  • How a new library is set to transform this underserved N.J. community
  • Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.

Archives

  • 2025
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,245)
  • Covid (985)
  • CTO Events (6)
  • News (2,860)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.